Growth Metrics

Tandem Diabetes Care (TNDM) Equity Income (2024 - 2026)

Tandem Diabetes Care filings provide 2 years of Equity Income readings, the most recent being -$4.6 million for Q4 2025.

  • On a quarterly basis, Equity Income fell 116.81% to -$4.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$14.1 million, a 572.76% decrease, with the full-year FY2025 number at -$14.2 million, down 575.9% from a year prior.
  • Equity Income hit -$4.6 million in Q4 2025 for Tandem Diabetes Care, down from -$2.7 million in the prior quarter.
  • In the past five years, Equity Income ranged from a high of -$2.1 million in Q4 2024 to a low of -$4.6 million in Q4 2025.